An interventional study of Oxytocin nasal spray and Placebo in Schizophrenia, sponsored by National Institute of Mental Health and Neuro Sciences, India. Completed. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-29.
Sponsored by National Institute of Mental Health and Neuro Sciences, India · Not applicable, Interventional, and Other
schizophrenia patients and healthy volunteers will be included. Subjects who meet the inclusion and exclusion criteria for the study will be recruited. After completion of clinical assessments and neuropsychological assessments, all subjects will undergo two fMRI scans. In one scan subjects will receive a single dose of intranasal oxytocin and in another scan, they will receive intranasal saline. The order of administration of oxytocin or saline will be counterbalanced so that they are not administered in the same order to all subjects. Subjects will be blind to the drug administered.
Schizophrenia group -
Inclusion Criteria:
Exclusion Criteria:
Healthy volunteers:
Inclusion Criteria:
Exclusion criteria:
Single-dose intranasal oxytocin or intranasal placebo administered in counterbalanced order
Drug: Oxytocin nasal spray
Single-dose intranasal oxytocin or intranasal placebo administered in counterbalanced order
Drug: Placebo
Single-dose oxytocin will be administered intranasally
fMRI changes with oxytocin while performing ultimatum game and at rest
Changes in brain activity and functional connectivity
Time frame: 90 minutes
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Mental Health and Neuro Sciences, India